medical

Elevaris Medical Devices Names New Chief Engineering and Operations Officer

BOSTON, Oct. 31, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization for industry-leading multi-national healthcare companies,…

1 month ago

Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care

Results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 in San Francisco on October 27, 2025 DynamX® bioadaptor…

1 month ago

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

October 26, 2025 19:15 ET  | Source: Vivani Medical, Inc. ALAMEDA, Calif., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical,…

1 month ago

Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION Platform at the European Society of Medical Oncology Annual Congress

October 19, 2025 10:00 ET  | Source: AVACTA GROUP PLC Median progression free survival (PFS) has not been reached in…

2 months ago

Cirtec Medical Appoints Steven Chevillotte to its Board of Directors

October 01, 2025 13:01 ET  | Source: Cirtec Medical BROOKLYN PARK, Minn., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical,…

2 months ago

Jharkhand Charcha 2025: The/Nudge Institute, Manipal TATA Medical College (MTMC), and Manipal Foundation co-host a convening on pathways for Jharkhand’s inclusive growth

250+ leaders unite in Ranchi to chart systemic pathways for livelihoods, equity, and climate resilience in JharkhandJharkhand Charcha 2025 calls…

2 months ago

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

September 11, 2025 17:01 ET  | Source: Achieve Life Sciences SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE)…

3 months ago

Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need

~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension~…

3 months ago

Kasturba Medical College, Manipal, launches Department of Artificial Intelligence (AI) in Healthcare

First of its kind in a Medical College in IndiaTo serve as an interdisciplinary hub, uniting medicine, engineering, and data…

3 months ago